Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
BIGT ETF · L&G Pharma Breakthrough UCITS ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +7.78%  | -1.14%  | +33.10% | +17.23% | +7.42% | +1.93% | +1.93% | +0.47% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -1.14% | +33.10%  | +17.23% | +7.42% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about BIGT ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
BIGT’s has a Final Sustainability Grade of either B+, B, or B-.
Replication
Issuer
| AuM | ||
|---|---|---|
ISPY | L&G Cyber Security UCITS ETF | €2.24B |
AIAG | L&G Artificial Intelligence UCITS ETF | €1.44B |
LGUS | L&G US Equity UCITS ETF | €1.21B |
ROBO | L&G ROBO Global Robotics and Automation UCITS ETF | €1.14B |
ENCO | L&G Multi-Strategy Enhanced Commodities UCITS ETF | €1.13B |
Frequently asked questions about BIGT
What does L&G Pharma Breakthrough UCITS ETF, BIGT, invest in?
BIGT is a Passive ETF. This ETF provides exposure to Other Equities.
Which benchmark or index does BIGT replicate?
BIGT tracks the Solactive Pharma Breakthrough Value NTR Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of BIGT?
BIGT carries a total expense ratio (TER) of 0.49%, indicating the annual cost for holding the fund.
When was BIGT launched?
BIGT was introduced to the market on January 23, 2018. It trades on Luxembourg, among other exchanges
Who is the ETF issuer of BIGT?
L&G Pharma Breakthrough UCITS ETF, BIGT, is provided by L&G. Learn more about L&G here.
What is the current assets under management (AUM) of BIGT?
BIGT oversees €16M in assets as of April 24, 2026.
How has BIGT performed lately?
Based on data from April 24, 2026, BIGT returned 7.78% over the past month, -1.14% over the last three months and 0.47% year-to-date.
What are the latest inflows or outflows for BIGT?
As of April 24, 2026, BIGT recorded net flows of -€1.2M over the last month and -€582K year-to-date.
Does BIGT distribute dividends?
BIGT follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of BIGT?
As of March 31, 2026, BIGT has significant geographic allocations in USA, Japan and Spain.
In which sector or theme does BIGT invest in?
As of March 31, 2026, BIGT focuses largely on Health Care and Materials.
How many securities does BIGT hold and how diversified is it?
As of March 31, 2026, BIGT holds 36 positions in its portfolio, with 44.55% of assets concentrated in its top 15 holdings.
What are the main positions in BIGT?
As of March 31, 2026, BIGT top three holdings include SAREPTA THERAPEUTICS INC DE, BIOCRYST PHARMACEUTICALS and PHARMA MAR SA.
What is the base currency of BIGT?
The base currency of BIGT is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
